These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 4423617)
1. [Therapeutic trial of Peyronie's disease using methylhydrazine]. Aboulker P; Benassayag E J Urol Nephrol (Paris); 1974 Jun; 80(6):554-6. PubMed ID: 4423617 [No Abstract] [Full Text] [Related]
2. Are the current conservative treatments for Peyronie's disease evidence-based? Gontero P; Frea B BJU Int; 2004 Jul; 94(1):3-4. PubMed ID: 15217420 [No Abstract] [Full Text] [Related]
3. Oral therapy for Peyronie's disease. Mynderse LA; Monga M Int J Impot Res; 2002 Oct; 14(5):340-4. PubMed ID: 12454684 [TBL] [Abstract][Full Text] [Related]
4. [Results of an immunodepressive treatment in La Peyronie's disease, Dupuytren's disease and certain sclerodermas]. Sturm M; Lebeuf M Bull Soc Fr Dermatol Syphiligr; 1971; 78(5):523-5. PubMed ID: 5152896 [No Abstract] [Full Text] [Related]
5. [Conservative treatment of Peyronie's disease with vitamin E and hydrocortisone]. Novak GIa Vestn Dermatol Venerol; 1984 Aug; (8):63-8. PubMed ID: 6485543 [No Abstract] [Full Text] [Related]
7. Review of current nonsurgical management of Peyronie's disease. Levine LA Int J Impot Res; 2003 Oct; 15 Suppl 5():S113-20. PubMed ID: 14551587 [TBL] [Abstract][Full Text] [Related]
8. Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective? Carson CC Tech Urol; 1997; 3(3):135-9. PubMed ID: 9422444 [TBL] [Abstract][Full Text] [Related]
9. [Personal results of treatment in penile induration (Peyronie's disease) and some remarks on pertinent therapeutic problems]. Chojna JW Pol Przegl Chir; 1971 Oct; 43(10):1611-6. PubMed ID: 5137430 [No Abstract] [Full Text] [Related]
10. [Therapeutic means in Peyronie's disease]. Llopis M; Allona A; Navío S; Jiménez M; Escudero A Arch Esp Urol; 1988; 41(9):873-5. PubMed ID: 3228314 [No Abstract] [Full Text] [Related]
12. Management of Peyronie's disease with penile prostheses. Mulcahy JJ; Wilson SK Int J Impot Res; 2002 Oct; 14(5):384-8. PubMed ID: 12454690 [TBL] [Abstract][Full Text] [Related]
13. The treatment of loss of penile rigidity associated with Peyronie's disease. Krane RJ Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682 [TBL] [Abstract][Full Text] [Related]
14. Iontophoresis for treatment of Peyronie's disease. Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323 [TBL] [Abstract][Full Text] [Related]
15. Orgotein, a new drug for the treatment of Peyronie's disease. Bartsch G; Menander-Huber KB; Huber W; Marberger H Eur J Rheumatol Inflamm; 1981; 4(2):250-9. PubMed ID: 7044791 [TBL] [Abstract][Full Text] [Related]
17. Use of dimethyl sulfoxide (DMSO) in Peyronie's disease; a preliminary report. Scheinman LJ; Miller EV Pac Med Surg; 1967; 75(1):61-2. PubMed ID: 6044596 [No Abstract] [Full Text] [Related]
19. Orgotein in the treatment of plastic induration of the penis (Peyronie's disease). Primus G Int Urol Nephrol; 1993; 25(2):169-72. PubMed ID: 8365848 [TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of Peyronie's disease. Carson CC Can J Urol; 2006 Feb; 13 Suppl 1():28-33. PubMed ID: 16526978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]